1 completed, 1 unknown. 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Unknown 1 |
| Phase 1 | 1 | Completed 1 |
Follow Dextroamphetamine Sulfate: new trials by email Literature Review of Dextroamphetamine Sulfate trials Research Report on Dextroamphetamine Sulfate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Abuse Liability, Pharmacokinetics, Safety and Tolerability of an Abuse-Deterrent d-Amphetamine Sulfate Immediate Release Formulation (ADAIR) ADAIR 10 mg IR tablets, d-amphetamine sulfate, Placebo - ADHD, Narcolepsy | Phase 1 | Completed | Vallon Pharmaceuticals, Inc. | 55 | 2020-10-05 | 2021-12-29 |
| Influence of Amphetamine-induced Sensitization on Dopamine Synthesis and Release Dextroamphetamine Sulfate - Schizophrenia, Psychosis | Not applicable | Unknown | Medical University of Vienna | 22 | 2018-01-01 | 2018-04-19 |
Attention Deficit Disorder with Hyperactivity (1) · Narcolepsy (1) · Psychotic Disorders (1) · Schizophrenia (1)
Medical University of Vienna (1) · Vallon Pharmaceuticals, Inc. (1)
Austria (1) · United States (1)
Ana Weidenauer, MD (1) · Timothy Whitaker, M (1)